CYP19A1 and digestive system disorder: The five side effects are as follows: gastrointestinal disorders, chemotherapy-induced peripheral neuropathy (CIPN), aromatase inhibitor-associated arthralgia (AIAA), aromatase inhibitor-associated joint problems (AIAS), and cognitive impairment.